Basic Info
  • Field of activity
    SEO
  • work experience
    2
Recent Updates
  • Bispecific Antibodies market Trends, Analysis by 2035

    Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder

    The USD 16.8 billion (by 2035) financial opportunity within bispecific antibodies market has been analyzed across the following segments:
     Therapeutic Area
     Autoimmune Disorders
     Genetic Disorders
     Hematological Malignancies
     Ophthalmic Disorders
     Skin Cancers
     Solid Tumors

     Mechanism of Action
     Cytokines Retargeting / Neutralization
     Dual Ligands Blocking
     Resistance Factors Co-targeting
     Targeting Tumor Angiogenesis
     T-Cell Retargeting / Activation
     Others

     Target Antigen
     C5-Albumin
     CD20 x CD3
     CD3 x BCMA
     CD3 x CD19
     EGFR x cMET
     EpCAM x CD3
     Factor IXa x Factor X
     gp100 x CD3
     HER2 x HER2
     PD-1 x CTLA-4
     PD-L1 x TGFβ
     TNF-α x HSA
     VEGF x DLL4
     VEGF-A x ANG2

     Antibody Format
     Asymmetric
     Fragments

     Key Players
     Akeso Biopharma
     Alexion
     Amgen
     Genmab
     Immunocore
     Janssen Research & Development
     Linton Pharm
     Merck
     OncXerna Therapeutics
     Pfizer
     Roche
     Taisho Pharmaceutical
     Zymeworks

     Key Geographical Regions
     Asia
     Europe
     North America
     Rest of the World

    The Bispecific Antibodies Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:
     Akeso Biopharma
     Alphamab Oncology
     Amgen
     Merck
     Regeneron
     Roche
     Xencor

    Table of Contents
    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape of Approved and Clinical Therapies

    5. Market Landscape of Preclinical Therapies

    6. Key Insights

    7. Technology Assessment Framework

    8. Big Pharma Players: Benchmarking Analysis

    9. Company Profiles

    10. Partnerships and Collaborations

    11. Contract Services for Bispecific Antibody Therapeutics

    12. Clinical Trial Analysis
    13. Case Study: Regulatory Guidelines for Bispecific Antibodies

    14. Case Study: Promotional / Marketing Strategies

    15. Market Forecast and Opportunity Analysis

    16. SWOT Analysis

    17. Concluding Remarks

    18. Executive insights

    19. Appendix 1: Tabulated data

    20. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

    Learn from experts: do you know about these emerging industry trends?
    Top 10 Companies Offering Oral Solid Dosage Manufacturing Services
    Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #BispecificAntibodiesMarket #BispecificAntibodiesMarketSize #bispecificantibody #bispecificantibodies #approvedbispecificantibodies
    Bispecific Antibodies market Trends, Analysis by 2035 Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder The USD 16.8 billion (by 2035) financial opportunity within bispecific antibodies market has been analyzed across the following segments:  Therapeutic Area  Autoimmune Disorders  Genetic Disorders  Hematological Malignancies  Ophthalmic Disorders  Skin Cancers  Solid Tumors  Mechanism of Action  Cytokines Retargeting / Neutralization  Dual Ligands Blocking  Resistance Factors Co-targeting  Targeting Tumor Angiogenesis  T-Cell Retargeting / Activation  Others  Target Antigen  C5-Albumin  CD20 x CD3  CD3 x BCMA  CD3 x CD19  EGFR x cMET  EpCAM x CD3  Factor IXa x Factor X  gp100 x CD3  HER2 x HER2  PD-1 x CTLA-4  PD-L1 x TGFβ  TNF-α x HSA  VEGF x DLL4  VEGF-A x ANG2  Antibody Format  Asymmetric  Fragments  Key Players  Akeso Biopharma  Alexion  Amgen  Genmab  Immunocore  Janssen Research & Development  Linton Pharm  Merck  OncXerna Therapeutics  Pfizer  Roche  Taisho Pharmaceutical  Zymeworks  Key Geographical Regions  Asia  Europe  North America  Rest of the World The Bispecific Antibodies Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Akeso Biopharma  Alphamab Oncology  Amgen  Merck  Regeneron  Roche  Xencor Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape of Approved and Clinical Therapies 5. Market Landscape of Preclinical Therapies 6. Key Insights 7. Technology Assessment Framework 8. Big Pharma Players: Benchmarking Analysis 9. Company Profiles 10. Partnerships and Collaborations 11. Contract Services for Bispecific Antibody Therapeutics 12. Clinical Trial Analysis 13. Case Study: Regulatory Guidelines for Bispecific Antibodies 14. Case Study: Promotional / Marketing Strategies 15. Market Forecast and Opportunity Analysis 16. SWOT Analysis 17. Concluding Remarks 18. Executive insights 19. Appendix 1: Tabulated data 20. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html Learn from experts: do you know about these emerging industry trends? Top 10 Companies Offering Oral Solid Dosage Manufacturing Services Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #BispecificAntibodiesMarket #BispecificAntibodiesMarketSize #bispecificantibody #bispecificantibodies #approvedbispecificantibodies
    0 Comments 0 Shares
  • Fill Finish Biopharmaceuticals market, Industry Analysis, and Forecast to 2035

    Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

    This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

    The financial opportunity within the biologics fill finish services market has been analysed across the following segments:

     Type of Packaging Container
     Ampoules
     Cartridges
     Syringes
     Vials

     Type of Biologic
     Antibodies
     Cell Therapies
     Gene Therapies
     Oligonucleotides
     Proteins / Peptides
     Vaccines
     Others

     Therapeutic Area
     Oncological Disorders
     Autoimmune Disorders
     Infectious Diseases
     Cardiovascular Disorders
     Other Disorders

     Scale of Operation
     Preclinical / Clinical
     Commercial

     Company Size
     Large
     Mid-sized
     Small

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Middle East and North Africa
     Latin America

    The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
     AbbVie Contract Manufacturing
     Asymchem
     BioReliance
     Boehringer Ingelheim BioXcellence
     Catalent Biologics
     Charles River Laboratories
     Fareva
     Fresenius Kabi
     Glaxo SmithKline
     Hetero Drugs
     Intas Pharmaceuticals
     Lonza
     Patheon
     Pierre Fabre
     Recipharm
     Samsun Biologics
     Syngene
     Takara Bio
     Wacker Biotech
     WuXi AppTec
     WuXi Biologics

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Biologics Fill / Finish Service Providers: Market Landscape

    5. Company Competitiveness Analysis

    6. Biologics Fill / Finish Service Providers in North America

    7. Biologics Fill / Finish Service Providers in Europe

    8. Biologics Fill / Finish Service Providers in Asia-Pacific

    9. Recent Partnerships

    10. Recent Expansions

    11. Capacity Analysis

    12. Demand Analysis

    13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

    14. Regional Capability Assessment

    15. Biologics Fill Finish Market Sizing and Opportunity Analysis

    16. Future Growth Opportunities

    17. Case Study: Robotic Systems in Fill / Finish Operations

    18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

    19. Concluding Remarks

    20. Executive Insights

    21. Appendix 1: Tabulated Data

    22. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html

    News article
    women's digital health market

    Learn from experts: do you know about these emerging industry trends?
    Bioavailability Enhancement Technologies
    TIL Therapies: A New Paradigm in Cancer Treatment

    Learn from our recently published whitepaper: -
    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #FillFinishBiopharmaceuticalsMarketGrowth#FillFinishBiopharmaceuticalsMarketTrends#Fillfinishmarket#FillFinishManufacturingMarket#FillFinishServiceMarket
    Fill Finish Biopharmaceuticals market, Industry Analysis, and Forecast to 2035 Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products. This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities. The financial opportunity within the biologics fill finish services market has been analysed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biologics Fill / Finish Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Biologics Fill / Finish Service Providers in North America 7. Biologics Fill / Finish Service Providers in Europe 8. Biologics Fill / Finish Service Providers in Asia-Pacific 9. Recent Partnerships 10. Recent Expansions 11. Capacity Analysis 12. Demand Analysis 13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish 14. Regional Capability Assessment 15. Biologics Fill Finish Market Sizing and Opportunity Analysis 16. Future Growth Opportunities 17. Case Study: Robotic Systems in Fill / Finish Operations 18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish 19. Concluding Remarks 20. Executive Insights 21. Appendix 1: Tabulated Data 22. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html News article women's digital health market Learn from experts: do you know about these emerging industry trends? Bioavailability Enhancement Technologies TIL Therapies: A New Paradigm in Cancer Treatment Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishBiopharmaceuticalsMarketGrowth#FillFinishBiopharmaceuticalsMarketTrends#Fillfinishmarket#FillFinishManufacturingMarket#FillFinishServiceMarket
    0 Comments 0 Shares
  • Medical Device Coating market Analysis and Trends by 2023-2035

    Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

    Roots Analysis has announced the addition of “Medical Device Coating Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of medical coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

    Amongst other elements, the report includes:
     A detailed executive summary of the insights captured during our research.
     A detailed assessment of the current market landscape of medical device coating providers.
     Detailed competitiveness analysis of various medical device coating providers.
     A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.
     Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.
     Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.
     An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.
     An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.
     A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Type of Devices Coated
     Class I Medical Devices
     Class II Medical Devices
     Class III Medical Devices

     Type of Coating Material
     Polymer Coatings
     Metal Coatings
     Other Coatings

     Company Size
     Very Small
     Small
     Mid-sized
     Large
     Very Large

     Key Geographical Region
     North America
     Europe
     Asia
     Rest of the World

    Key companies covered in the report
     Advanced Coating
     Biocoat
     Evonik
     Formacoat
     Harland Medical Systems
     Para-Coat Technologies
     Specialty Coating Systems
     SurModics
     TUA Systems

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/medical-device-coatings-market.html

    Learn from experts: do you know about these emerging industry trends?
    Introduction To Exosome Therapeutics
    Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #MedicalDeviceCoatingMarket #MedicalDeviceCoatingMarketSize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies
    Medical Device Coating market Analysis and Trends by 2023-2035 Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry Roots Analysis has announced the addition of “Medical Device Coating Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of medical coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed executive summary of the insights captured during our research.  A detailed assessment of the current market landscape of medical device coating providers.  Detailed competitiveness analysis of various medical device coating providers.  A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.  Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.  An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.  An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.  A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Devices Coated  Class I Medical Devices  Class II Medical Devices  Class III Medical Devices  Type of Coating Material  Polymer Coatings  Metal Coatings  Other Coatings  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Region  North America  Europe  Asia  Rest of the World Key companies covered in the report  Advanced Coating  Biocoat  Evonik  Formacoat  Harland Medical Systems  Para-Coat Technologies  Specialty Coating Systems  SurModics  TUA Systems To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/medical-device-coatings-market.html Learn from experts: do you know about these emerging industry trends? Introduction To Exosome Therapeutics Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalDeviceCoatingMarket #MedicalDeviceCoatingMarketSize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies
    0 Comments 0 Shares
  • Automated Liquid Handling Systems market Research Report by 2023, Forecast till 2035

    The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.”

    The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes:
     An executive summary of the insights captured during our research.
     A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems.
     A detailed assessment of the current market landscape of automated pipetting systems, based on several relevant parameters.
     A detailed competitiveness analysis of automated pipetting system providers based on several relevant parameters
     Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated pipetting systems across North America, Europe and Asia-Pacific and rest of the world.
     A detailed assessment of the current market landscape of automated microplate washers, based on several relevant parameters.
     A detailed competitiveness analysis of automated microplate washer providers based on several relevant parameters.
     Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated microplate washers across North America, Europe and Asia-Pacific and rest of the world.
     A detailed analysis of partnerships inked between stakeholders engaged in this industry since 2018.
     An in-depth analysis of various patents that have been filed / granted related to automated liquid handling systems since 2018.
     A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

    Automated Pipetting Systems Market
     Pipetting Technology
     Contact Technology
     Air Displacement Technology
     Piston / Positive Displacement Technology
     Acoustic Technology
     Free-jet Technology

     Modality
     Fixed Tips
     Disposable Tips

     Type of Instrument
     Standalone
     Individual Benchtop Workstation
     Multi Instrument Systems
     Others

     Applications
     Serial Dilution
     Plate Replication
     PCR / qPCR Setup
     Plate Reformatting
     High-throughput Screening
     Whole Genome Amplification
     Cell Culture
     Other Applications

     End User
     Biotechnology and Pharmaceutical Companies
     Academic and Government Research Institutes
     Hospitals and Diagnostic Centers
     Other End Users

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Middle East and North Africa
     Latin America

    Automated Microplate Washers Market
     Washing Technology
     Ultrasonic Technology
     Acoustic Technology
     Centrifugal Technology

     Application
     ELISA
     Cell-based Assays
     Bead Washing
     Other Applications

     End-user
     Biotechnology and Pharmaceutical Companies
     Academic and Government Research Institutes
     Hospitals and Diagnostic Centers
     Other End Users

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Middle East and North Africa
     Latin America


    Key companies covered in the report
     Agilent Technologies
     Beckman Coulter Life Sciences
     Eppendorf
     Hamilton Robotics
     MyGenostics
     Tecan
     Thermo Fisher Scientific

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/automated-liquid-handling-systems-market.html

    News article
    Global Cell Free Expression Market

    Learn from experts: do you know about these emerging industry trends?
    Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry
    Top 10 Companies Offering Oral Solid Dosage Manufacturing Services

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com
    Automated Liquid Handling Systems market Research Report by 2023, Forecast till 2035 The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.” The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes:  An executive summary of the insights captured during our research.  A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems.  A detailed assessment of the current market landscape of automated pipetting systems, based on several relevant parameters.  A detailed competitiveness analysis of automated pipetting system providers based on several relevant parameters  Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated pipetting systems across North America, Europe and Asia-Pacific and rest of the world.  A detailed assessment of the current market landscape of automated microplate washers, based on several relevant parameters.  A detailed competitiveness analysis of automated microplate washer providers based on several relevant parameters.  Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated microplate washers across North America, Europe and Asia-Pacific and rest of the world.  A detailed analysis of partnerships inked between stakeholders engaged in this industry since 2018.  An in-depth analysis of various patents that have been filed / granted related to automated liquid handling systems since 2018.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Automated Pipetting Systems Market  Pipetting Technology  Contact Technology  Air Displacement Technology  Piston / Positive Displacement Technology  Acoustic Technology  Free-jet Technology  Modality  Fixed Tips  Disposable Tips  Type of Instrument  Standalone  Individual Benchtop Workstation  Multi Instrument Systems  Others  Applications  Serial Dilution  Plate Replication  PCR / qPCR Setup  Plate Reformatting  High-throughput Screening  Whole Genome Amplification  Cell Culture  Other Applications  End User  Biotechnology and Pharmaceutical Companies  Academic and Government Research Institutes  Hospitals and Diagnostic Centers  Other End Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Automated Microplate Washers Market  Washing Technology  Ultrasonic Technology  Acoustic Technology  Centrifugal Technology  Application  ELISA  Cell-based Assays  Bead Washing  Other Applications  End-user  Biotechnology and Pharmaceutical Companies  Academic and Government Research Institutes  Hospitals and Diagnostic Centers  Other End Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key companies covered in the report  Agilent Technologies  Beckman Coulter Life Sciences  Eppendorf  Hamilton Robotics  MyGenostics  Tecan  Thermo Fisher Scientific To view more details on this report, click on the link https://www.rootsanalysis.com/reports/automated-liquid-handling-systems-market.html News article Global Cell Free Expression Market Learn from experts: do you know about these emerging industry trends? Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry Top 10 Companies Offering Oral Solid Dosage Manufacturing Services About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
    0 Comments 0 Shares
  • Cell Free Expression market, Size and Share by 2035

    The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.”

    The cell free market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:
     An executive summary of insights captured during our research.
     A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique
     A detailed assessment of the current market landscape of cell free expression service providers.
     A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.
     A comprehensive company competitiveness analysis of cell free expression service providers.
     A product competitiveness analysis of cell free expression kits based on various relevant parameters.
     Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.
     Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).
     A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.
     An analysis of the funding and investments made in the cell free expression market, since 2018.
     An in-depth analysis of various patents that have been filed / granted related to cell free systems since 2015.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Type of Cell Free System
    • Crude Cell Lysate-based Systems
    • Reconstituted Systems

     Type of Host Organism
    • Microbial Cell Free Expression System
    • Mammalian Cell Free Expression Systems
    • Plant-based Cell Free Expression Systems
    • Other Cell Free Expression Systems

     Type of Expression Method
    • Coupled Transcription and Translation Method
    • Translation Method

     End-User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Other End-Users

     Key Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

    Key companies covered in the report
     BioLinker
     biotechrabbit
     CellFree Sciences
     Creative Biolabs
     CUSABIO
     Daicel Arbor Biosciences
     LenioBio
     Promega
     Thermo Fisher Scientific
     Touchlight

    For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html

    Learn from experts: do you know about these emerging industry trends?
    Digital Therapies: The “Digital Pills” of current generation
    Medical Device Coatings and Modification Technologies

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #CellFreeExpressionMarketTrends #CellFreeExpressionMarketGrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem
    Cell Free Expression market, Size and Share by 2035 The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.” The cell free market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:  An executive summary of insights captured during our research.  A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique  A detailed assessment of the current market landscape of cell free expression service providers.  A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.  A comprehensive company competitiveness analysis of cell free expression service providers.  A product competitiveness analysis of cell free expression kits based on various relevant parameters.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.  Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).  A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.  An analysis of the funding and investments made in the cell free expression market, since 2018.  An in-depth analysis of various patents that have been filed / granted related to cell free systems since 2015.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cell Free System • Crude Cell Lysate-based Systems • Reconstituted Systems  Type of Host Organism • Microbial Cell Free Expression System • Mammalian Cell Free Expression Systems • Plant-based Cell Free Expression Systems • Other Cell Free Expression Systems  Type of Expression Method • Coupled Transcription and Translation Method • Translation Method  End-User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Other End-Users  Key Geographical Regions • North America • Europe • Asia Pacific • Rest of the World Key companies covered in the report  BioLinker  biotechrabbit  CellFree Sciences  Creative Biolabs  CUSABIO  Daicel Arbor Biosciences  LenioBio  Promega  Thermo Fisher Scientific  Touchlight For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html Learn from experts: do you know about these emerging industry trends? Digital Therapies: The “Digital Pills” of current generation Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellFreeExpressionMarketTrends #CellFreeExpressionMarketGrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem
    0 Comments 0 Shares
  • Aseptic Fill Finish market Size, Share, Trends by 2035

    The growing concern to maintain pharmacological efficacy and product quality, to ensure patient’s safety, has led to a greater focus on the need for aseptic fill / finish; drug developers prefer to outsource these operations to benefit from the expertise of service providers

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Aseptic Fill Finish Market, 2023-2035”

    The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in aseptic fill / finish services market manufacturing. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A summary of the key insights derived from our research, which offers a high-level view on the likely evolution of the aseptic fill and finish service providers market in the short to mid-term, and long term.
     A general introduction to pharmaceuticals and contract manufacturing, which features a detailed discussion on the need for outsourcing within the pharmaceutical industry and key operations outsourced by biologic and small molecule drug developers, including fill finish. It also provides information on the key considerations for selecting a fill finish service provider, along with the advantages and risks posed by outsourcing fill finish operations.
     A detailed assessment of the overall landscape of aseptic fill finish service providers, along with information on several relevant parameters.
     A review of the overall landscape of companies offering aseptic fill finish services for biologics, along with analyses on a number of relevant parameters.
     A detailed assessment of the overall market landscape of the companies offering aseptic fill and finish services for small molecules, along with analyses on a number of relevant parameters.
     Tabulated profiles of key players based in North America, Europe and Asia-Pacific.
     A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain, since 2013.
     A case study focused on use of robotic systems in fill finish operations.
     A case study on use of ready-to-use packaging components in aseptic fill finish operations.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Type of Molecule
     Small molecules
     Biologics

     Type of Packaging Container
     Ampoules
     Cartridges
     Syringes
     Vials

     Type of Drug Product
     Antibodies
     Cell Therapies
     Gene Therapies
     Oligonucleotides
     Recombinant Proteins
     Vaccines
     Other Drug Products

     Target Therapeutic Area
     Autoimmune disorders
     Oncological Disorders
     Cardiovascular Disorders
     Infectious Diseases
     Other Disorders

     Scale Of Operation
     Preclinical / Clinical
     Commercial

     Company Size
     Large
     Mid-sized
     Small

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Middle East and North Africa
     Latin America

    Key companies covered in the report
     BD Biosciences
     AbbVie Contract Manufacturing
     Aenova
     APL
     Asymchem
     BD Biosciences
     BioPharma Solutions
     BioReliance
     Boehringer Ingelheim BioXcellence
     Catalent Biologics
     Charles River Laboratories
     CordenPharma
     Delpharm
     Fareva
     Fresenius Kabi
     GlaxoSmithKline
     Hetero Drugs
     Intas Pharmaceuticals
     Lonza
     Patheon
     Pfizer CentreOne
     Pierre Fabre
     PiSA Farmaceutica
     Plastikon Healthcare
     Recipharm
     Samsung Biologics
     Sharp Services
     Siegfried
     Syngene
     Takara Bio
     Wacker Biotech
     Wockhardt
     WuXi Biologics

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html

    News article
    cell and gene therapy CROs market

    Learn from experts: do you know about these emerging industry trends?
    TIL Therapies: A New Paradigm in Cancer Treatment
    Viral Clearance and Viral Testing Services

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #AsepticFillFinishMarket #AsepticFillFinishMarketSize #asepticfillfinish #sterilefillfinish #asepticfillfinishmanufacturing
    Aseptic Fill Finish market Size, Share, Trends by 2035 The growing concern to maintain pharmacological efficacy and product quality, to ensure patient’s safety, has led to a greater focus on the need for aseptic fill / finish; drug developers prefer to outsource these operations to benefit from the expertise of service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “Aseptic Fill Finish Market, 2023-2035” The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in aseptic fill / finish services market manufacturing. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A summary of the key insights derived from our research, which offers a high-level view on the likely evolution of the aseptic fill and finish service providers market in the short to mid-term, and long term.  A general introduction to pharmaceuticals and contract manufacturing, which features a detailed discussion on the need for outsourcing within the pharmaceutical industry and key operations outsourced by biologic and small molecule drug developers, including fill finish. It also provides information on the key considerations for selecting a fill finish service provider, along with the advantages and risks posed by outsourcing fill finish operations.  A detailed assessment of the overall landscape of aseptic fill finish service providers, along with information on several relevant parameters.  A review of the overall landscape of companies offering aseptic fill finish services for biologics, along with analyses on a number of relevant parameters.  A detailed assessment of the overall market landscape of the companies offering aseptic fill and finish services for small molecules, along with analyses on a number of relevant parameters.  Tabulated profiles of key players based in North America, Europe and Asia-Pacific.  A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain, since 2013.  A case study focused on use of robotic systems in fill finish operations.  A case study on use of ready-to-use packaging components in aseptic fill finish operations.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Molecule  Small molecules  Biologics  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Drug Product  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Recombinant Proteins  Vaccines  Other Drug Products  Target Therapeutic Area  Autoimmune disorders  Oncological Disorders  Cardiovascular Disorders  Infectious Diseases  Other Disorders  Scale Of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key companies covered in the report  BD Biosciences  AbbVie Contract Manufacturing  Aenova  APL  Asymchem  BD Biosciences  BioPharma Solutions  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  CordenPharma  Delpharm  Fareva  Fresenius Kabi  GlaxoSmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pfizer CentreOne  Pierre Fabre  PiSA Farmaceutica  Plastikon Healthcare  Recipharm  Samsung Biologics  Sharp Services  Siegfried  Syngene  Takara Bio  Wacker Biotech  Wockhardt  WuXi Biologics To view more details on this report, click on the link https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html News article cell and gene therapy CROs market Learn from experts: do you know about these emerging industry trends? TIL Therapies: A New Paradigm in Cancer Treatment Viral Clearance and Viral Testing Services About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #AsepticFillFinishMarket #AsepticFillFinishMarketSize #asepticfillfinish #sterilefillfinish #asepticfillfinishmanufacturing
    0 Comments 0 Shares
  • Analysis of DNA Encoded Library market Strategies and Forecasts to 2035

    The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification.

    The financial opportunity within the DNA encoded library market has been analyzed across the following segments:

     Application Area
     Hit Generation / Identification
     Hit to Lead
     Hit Validation / Optimization
     Other Application Areas

     Therapeutic Area
     Oncological Disorders
     Immunological Disorders
     Neurological Disorders
     Respiratory Disorders
     Dermatological Disorders
     Cardiovascular Disorders
     Infectious Diseases
     Other Therapeutic Areas

     End-user
     Pharma / Biopharma Industry
     Academic / Research Institute
     Other End-users

     Type of Payment Model Employed
     Upfront Payment
     Milestone Payment

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific

    The research also includes detailed profiles of key players (listed below) offering DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.
     AlphaMa
     DICE Therapeutics
     DyNAbind
     HitGen
     NovAliX
     Vipergen
     WuXi AppTec
     X-Chem




    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape

    5. Business Model Analysis

    6. Company Competitiveness Analysis

    7. Company Profiles

    8. Partnerships and Collaborations

    9. Global Event Analysis

    10. Patent Analysis

    11. Big Pharma Initiatives

    12. Case Study: Companies / Organizations Supporting the Development of DNA Encoded
    Libraries

    13. Market Forecast and Opportunity Analysis

    14. Concluding Remarks

    15. Executive Insights

    16. Appendix 1: Tabulated Data

    17. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/view_document/dna-encoded-libraries/288.html

    Learn from experts: do you know about these emerging industry trends?
    Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain
    CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

    Learn from our recently published whitepaper: -
    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #DNAEncodedLibraryMarketTrends #DNAEncodedLibraryMarketGrowth #dnaencodedlibraries #DELTechnology #xchem
    Analysis of DNA Encoded Library market Strategies and Forecasts to 2035 The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification. The financial opportunity within the DNA encoded library market has been analyzed across the following segments:  Application Area  Hit Generation / Identification  Hit to Lead  Hit Validation / Optimization  Other Application Areas  Therapeutic Area  Oncological Disorders  Immunological Disorders  Neurological Disorders  Respiratory Disorders  Dermatological Disorders  Cardiovascular Disorders  Infectious Diseases  Other Therapeutic Areas  End-user  Pharma / Biopharma Industry  Academic / Research Institute  Other End-users  Type of Payment Model Employed  Upfront Payment  Milestone Payment  Key Geographical Regions  North America  Europe  Asia-Pacific The research also includes detailed profiles of key players (listed below) offering DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.  AlphaMa  DICE Therapeutics  DyNAbind  HitGen  NovAliX  Vipergen  WuXi AppTec  X-Chem Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Business Model Analysis 6. Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Global Event Analysis 10. Patent Analysis 11. Big Pharma Initiatives 12. Case Study: Companies / Organizations Supporting the Development of DNA Encoded Libraries 13. Market Forecast and Opportunity Analysis 14. Concluding Remarks 15. Executive Insights 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/dna-encoded-libraries/288.html Learn from experts: do you know about these emerging industry trends? Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DNAEncodedLibraryMarketTrends #DNAEncodedLibraryMarketGrowth #dnaencodedlibraries #DELTechnology #xchem
    0 Comments 0 Shares
  • Intracellular Drug Delivery market Analysis and Trends by 2023-2035

    The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol

    The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:
     Type of Molecule
     Small Molecule
     Biologic

     Type of Biologic
     Antibodies
     DNA
     RNA
     Proteins / Peptides

     Type of Intracellular Drug Delivery Technologies
     Cell Penetrating Peptides
     Extracellular Vesicles
     Oligonucleotides
     Nanoparticles
     Polymers

     Target Therapeutic Area
     Infectious Diseases
     Oncological Disorders
     Genetic Disorders
     Neurological Disorders
     Hepatic Disorders
     Cardiovascular Disorders
     Other Disorders

     Type Of Payment Model
     Upfront Payments
     Milestone Payments

     Key Geographical Regions
     North America
     Europe
     Asia
     Latin America
     Middle East and North Africa (MENA)
     Rest of the world

    The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:
     Alnylam Pharmaceuticals
     AstraZeneca
     Biond Biologics
     Code Biotherapeutics
     Eli Lilly
     Merck
     Novartis
     Roche

    Table of Contents
    1. Preface
    2. Executive Summary
    3. Introduction
    4. Market Landscape
    5. Key Insights
    6. Company Competitiveness Analysis
    7. Company Profiles
    8. Patent Analysis
    9. Partnerships and Collaborations
    10. Opportunity Assessment Framework
    11. Market Forecast
    12. Conclusion
    13. Executive insights
    14. Appendix I: Tabulated data
    15. Appendix II: List of Companies and Organizations

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

    News article
    AI-based Digital Pathology Market

    Learn from experts: do you know about these emerging industry trends?
    Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
    Exploring How Artificial Intelligence Is Transforming Digital Pathology

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #IntracellularDrugDeliveryMarket #IntracellularDrugDeliveryMarketSize #DrugDeliverySystems #IntracellularDrugDelivery #CellPenetratingPeptides
    Intracellular Drug Delivery market Analysis and Trends by 2023-2035 The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:  Type of Molecule  Small Molecule  Biologic  Type of Biologic  Antibodies  DNA  RNA  Proteins / Peptides  Type of Intracellular Drug Delivery Technologies  Cell Penetrating Peptides  Extracellular Vesicles  Oligonucleotides  Nanoparticles  Polymers  Target Therapeutic Area  Infectious Diseases  Oncological Disorders  Genetic Disorders  Neurological Disorders  Hepatic Disorders  Cardiovascular Disorders  Other Disorders  Type Of Payment Model  Upfront Payments  Milestone Payments  Key Geographical Regions  North America  Europe  Asia  Latin America  Middle East and North Africa (MENA)  Rest of the world The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:  Alnylam Pharmaceuticals  AstraZeneca  Biond Biologics  Code Biotherapeutics  Eli Lilly  Merck  Novartis  Roche Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Key Insights 6. Company Competitiveness Analysis 7. Company Profiles 8. Patent Analysis 9. Partnerships and Collaborations 10. Opportunity Assessment Framework 11. Market Forecast 12. Conclusion 13. Executive insights 14. Appendix I: Tabulated data 15. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html News article AI-based Digital Pathology Market Learn from experts: do you know about these emerging industry trends? Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #IntracellularDrugDeliveryMarket #IntracellularDrugDeliveryMarketSize #DrugDeliverySystems #IntracellularDrugDelivery #CellPenetratingPeptides
    0 Comments 0 Shares
  • Non-Viral Transfection Reagents market Share, Growth Analysis by 2035

    Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents.

    Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.

    The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:

     Non-Viral Based Transfection Methods
     Chemical-based Methods
     Physical-based Methods
     Other Methods

     End-Users
     Academic And Research Institutions
     Stem Pharmaceutical Companies
     Other End-Users

     Area of Application
     Clinical Applications
     Research Applications

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Rest of the World (RoW)

    The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:
     BEX
     Bio-Rad Laboratories
     BTX
     Celsion Corporation
     Genprex
     Inovio Pharmaceuticals
     MaxCyte
     MilliporeSigma
     NepaGene
     OZ Biosciences
     Thermo Fisher Scientific

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Non-Viral Transfection Reagents: Market Landscape

    5. Electroporation-Based Transfection Systems: Market Landscape

    6. Other Non-Viral Transfection Systems: Market Landscape

    7. Company Competitiveness Analysis

    8. Technology Competitiveness Analysis

    9. Company Profiles

    10. Potential Strategic Partners

    11. Big Pharma Initiatives

    12. Patent Analysis

    13. Publication Analysis

    14. Roots Analysis Pricing Strategy Framework

    15. Market Sizing and Opportunity Analysis

    16. Executive Insights

    17. Conclusion

    18. Appendix 1: Tabulated Data

    19. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/view_document/non-viral-transfection/307.html

    Learn from experts: do you know about these emerging industry trends?
    Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
    Digital Therapies: The “Digital Pills” of current generation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #NonViralTransfectionReagentsMarket #NonViralTransfectionReagentsMarketSize #NonViralTransfection #TransfectionReagents #NonViralTransfectionReagents
    Non-Viral Transfection Reagents market Share, Growth Analysis by 2035 Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents. Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future. The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:  Non-Viral Based Transfection Methods  Chemical-based Methods  Physical-based Methods  Other Methods  End-Users  Academic And Research Institutions  Stem Pharmaceutical Companies  Other End-Users  Area of Application  Clinical Applications  Research Applications  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World (RoW) The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:  BEX  Bio-Rad Laboratories  BTX  Celsion Corporation  Genprex  Inovio Pharmaceuticals  MaxCyte  MilliporeSigma  NepaGene  OZ Biosciences  Thermo Fisher Scientific Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Non-Viral Transfection Reagents: Market Landscape 5. Electroporation-Based Transfection Systems: Market Landscape 6. Other Non-Viral Transfection Systems: Market Landscape 7. Company Competitiveness Analysis 8. Technology Competitiveness Analysis 9. Company Profiles 10. Potential Strategic Partners 11. Big Pharma Initiatives 12. Patent Analysis 13. Publication Analysis 14. Roots Analysis Pricing Strategy Framework 15. Market Sizing and Opportunity Analysis 16. Executive Insights 17. Conclusion 18. Appendix 1: Tabulated Data 19. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/non-viral-transfection/307.html Learn from experts: do you know about these emerging industry trends? Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities Digital Therapies: The “Digital Pills” of current generation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #NonViralTransfectionReagentsMarket #NonViralTransfectionReagentsMarketSize #NonViralTransfection #TransfectionReagents #NonViralTransfectionReagents
    0 Comments 0 Shares
  • Digital Biomanufacturing market 2023 – Industry Growth by 2035

    Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights.

    In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies.

    The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:
     Type of Technology
     Process Analytical Technology (PAT)
     Data Analysis Software (DAS)
     Manufacturing Execution Systems (MES)
     Digital Twins

     Deployment Options
     Cloud-based Deployment Options
     On-premises Deployment Options

     Type(s) of Biologic(s) Manufactured
     Antibodies
     Cell and Gene Therapies
     Proteins
     Vaccines
     Others

     Geographical Regions
     North America
     Europe
     Asia Pacific
     Latin America
     Middle East and North America

    The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
     AspenTech
     Bioreactors.net
     Dassault Systèmes
     FUJIFILM Diosynth Biotechnologies
     GE Healthcare
     Körber
     Merck
     Sartorius
     Thermo Fisher Scientific

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape
    5. Technology Competitiveness Analysis
    6. Company Profiles
    7. Benchmarking Analysis
    8. Partnerships and Collaborations
    9. Market Concentration Analysis
    10. Industry Lifecycle Analysis
    11. Market Forecast and Opportunity Analysis
    12. Concluding Remarks
    13. Interview Transcripts
    14. Appendix I: Tabulated Data
    15. Appendix II: List of Companies and Organizations

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html

    Learn from experts: do you know about these emerging industry trends?
    Applications of Blockchain in Various Sectors: An Introduction
    Intracellular Drug Delivery – Future Potential

    Learn from our recently published whitepaper: -
    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies

    Digital Biomanufacturing market 2023 – Industry Growth by 2035 Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights. In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies. The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:  Type of Technology  Process Analytical Technology (PAT)  Data Analysis Software (DAS)  Manufacturing Execution Systems (MES)  Digital Twins  Deployment Options  Cloud-based Deployment Options  On-premises Deployment Options  Type(s) of Biologic(s) Manufactured  Antibodies  Cell and Gene Therapies  Proteins  Vaccines  Others  Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North America The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  AspenTech  Bioreactors.net  Dassault Systèmes  FUJIFILM Diosynth Biotechnologies  GE Healthcare  Körber  Merck  Sartorius  Thermo Fisher Scientific Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Technology Competitiveness Analysis 6. Company Profiles 7. Benchmarking Analysis 8. Partnerships and Collaborations 9. Market Concentration Analysis 10. Industry Lifecycle Analysis 11. Market Forecast and Opportunity Analysis 12. Concluding Remarks 13. Interview Transcripts 14. Appendix I: Tabulated Data 15. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html Learn from experts: do you know about these emerging industry trends? Applications of Blockchain in Various Sectors: An Introduction Intracellular Drug Delivery – Future Potential Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies
    0 Comments 0 Shares
More Stories